论文部分内容阅读
早产儿贫血是影响早产儿成活及生存质量的常见问题之一,且易出现并发症。引起早产儿贫血的原因中,促红细胞生成素(EPO)水平低下被认为是最重要的原因[1]。本文中我们观察了加用EPO对防治早产儿贫血的影响。1对象与方法1.1对象衡水市桃城区妇幼保健院住院分娩的早产儿86例,均于生后即转入本院儿科治疗。其中,男46例,女40例;胎龄为31～34周,出生体重1300～2100g,86例早产儿出生时均无血液系统疾病,无贫血、失血,无红细胞增多,未发现溶血及先天性疾病,不伴感染,病情相对平稳,治疗过程中无高疸换血者。1.2方法将86例早产儿随机分为EPO治疗组和对照组,各43例,其出生体重、胎龄、血红蛋白(Hb)、网织红细胞(Ret)和男
Premature children with anemia is one of the common problems affecting the survival and quality of life of premature infants, and prone to complications. Among the causes of anemia in preterm infants, the low level of erythropoietin (EPO) is considered to be the most important cause [1]. In this article we looked at the effects of the addition of EPO on the prevention and treatment of anemia in preterm infants. 1 Subjects and Methods 1.1 Object Tao City MCH in Hengshui hospital delivery of 86 cases of premature children, were transferred to our hospital pediatric treatment after birth. Among them, 46 males and 40 females; gestational age of 31 to 34 weeks, birth weight 1300 ~ 2100g, 86 cases of premature children born with no blood diseases, no anemia, blood loss, no erythrocytosis, no hemolysis and congenital Sexually transmitted diseases, without infection, the condition is relatively stable, no jaundice in the course of treatment transfusion. 1.2 Methods 86 cases of premature children were randomly divided into EPO treatment group and control group, 43 cases of each birth weight, gestational age, hemoglobin (Hb), reticulocyte (Ret) and male